Robert Blaustein
Chief Development Officer · Edgewise Therapeutics, Inc.
Individual
- 2025
- Aug 12, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Blaustein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alan J. Russell - $10.25M in EWTX purchases and sales in the last 12 months
- Joanne M. Donovan - $4.62M in EWTX purchases and sales in the last 12 months
- Badreddin Edris - $3.40M in EWTX purchases and sales in the last 12 months
- Kevin Koch - $785K in EWTX purchases and sales in the last 12 months
- Behrad Derakhshan - $223K in EWTX purchases and sales in the last 12 months
- John R. Moore - $220K in EWTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Blaustein?
Robert Blaustein is a corporate insider, tracked as Chief Development Officer of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert Blaustein last file a Form 4?
The only primary Form 4 on record is dated 12 August 2025.